Catalog Home Page

Publications: Baker, Ross

Stats for Baker, Ross
Export as [feed] RSS
Group by: Publication Type | Year
Number of items: 19.

Journal Article

Tay, J., Romeo, G., Hughes, Q. and Baker, R. (2013) Downregulation of protein S by oestrogens and miR-494. Journal of Thrombosis and Haemostasis, 11 (Supp. 2). p. 253.

Kuter, D.J., Bussel, J.B., Newland, A., Baker, R.I., Lyons, R.M., Wasser, J., Viallard, J-F, Macik, G., Rummel, M., Nie, K. and Jun, S. (2013) Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: Safety and efficacy. British Journal of Haematology, 161 (3). pp. 411-423.

Tay, J.W., Romeo, G., Hughes, Q.W. and Baker, R.I. (2013) Micro-Ribonucleic Acid 494 regulation of protein S expression. Journal of Thrombosis and Haemostasis, 11 (8). pp. 1547-1555.

Powell, J.S., Pasi, K.J., Ragni, M.V., Ozelo, M.C., Valentino, L.A., Mahlangu, J.N., Josephson, N.C., Perry, D., Manco-Johnson, M.J., Apte, S., Baker, R.I., Chan, G.C., Novitzky, N., Wong, R.S., Krassova, S., Allen, G., Jiang, H., Innes, A., Li, S., Cristiano, L.M., Goyal, J., Sommer, J.M., Dumont, J.A., Nugent, K., Vigliani, G., Brennan, A., Luk, A. and Pierce, G.F. (2013) Phase 3 study of recombinant factor IX Fc fusion protein in Hemophilia B. New England Journal of Medicine, 369 (24). pp. 2313-2323.

Herrmann, R., Thom, J., Wood, A., Phillips, M, Muhammad, S. and Baker, R. (2013) Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban. Thrombosis and Haemostasis, 111 (5). pp. 989-995.

Cheng, Y.-C., Anderson, C.D., Bione, S., Keene, K., Maguire, J.M., Nalls, M., Rasheed, A., Zeginigg, M., Attia, J., Baker, R., Barlera, S., Biffi, A., Bookman, E., Brott, T.G., Brown, R. D., Chen, F., Chen, W.-M., Ciusani, E., Cole, J.W., Cortellini, L., Danesh, J., Doheny, K., Ferrucci, L., Grazia Franzosi, M., Frossard, P., Furie, K.L., Golledge, J., Hankey, G.J., Hernandez, D., Holliday, E.G., Hsu, F.-C., Jannes, J., Kamal, A., Khan, M.S., Kittner, S.J., Koblar, S.A., Lewis, M., Lincz, L., Lisa, A., Matarin, M., Moscato, P., Mychaleckyj, J.C., Parati, E.A., Parolo, S., Pugh, E., Rost, N.S., Schallert, M., Schmidt, H., Scott, R.J., Sturm, J.W., Yadav, S., Zaidi, M., Boncoraglio, G.B., Levi, C.R., Meschia, J.F., Rosand, J., Sale, M., Saleheen, D., Schmidt, R., Sharma, P., Worrall, B. and Mitchell, B.D. (2012) Are myocardial infarction-associated single-nucleotide polymorphisms associated with ischemic stroke? Stroke, 43 (4). pp. 980-986.

Holliday, E.G., Maguire, J.M., Evans, T-J, Koblar, S.A., Jannes, J., Sturm, J.W., Hankey, G.J., Baker, R., Golledge, J., Parsons, M.W., Malik, R., McEvoy, M., Biros, E., Lewis, M.D., Lincz, L.F., Peel, R., Oldmeadow, C., Smith, W., Moscato, P., Barlera, S., Bevan, S., Bis, J.C., Boerwinkle, E., Boncoraglio, G.B., Brott, T.G., Brown, R.D., Cheng, Y-C, Cole, J.W., Cotlarciuc, I., Devan, W.J., Fornage, M., Furie, K.L., Grétarsdóttir, S., Gschwendtner, A., Ikram, M.A., Longstreth, W.T., Meschia, J.F., Mitchell, B.D., Mosley, T.H., Nalls, M.A., Parati, E.A., Psaty, B.M., Sharma, P., Stefansson, K., Thorleifsson, G., Thorsteinsdottir, U., Traylor, M., Verhaaren, B.F.J., Wiggins, K.L., Worrall, B.B., Sudlow, C., Rothwell, P.M., Farrall, M., Dichgans, M., Rosand, J., Markus, H.S., Scott, R.J., Levi, C. and Attia, J. (2012) Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nature Genetics, 44 (10). pp. 1147-1151.

Al-Tamimi, M., Gardiner, E.E., Thom, J.Y., Shen, Y., Cooper, M.N., Hankey, G.J., Berndt, M.C., Baker, R.I. and Andrews, R.K. (2011) Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke. Stroke, 42 (2). pp. 498-500.

Dunkley, S., Baker, R.I., Pidcock, M., Price, J., Seldon, M., Smith, M., Street, A., Maher, D., Barrese, G., Stone, C. and Lloyd, J. (2010) Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE® in patients with von Willebrand’s disease: a prospective multi-centre study. Haemophilia, 16 (4). pp. 615-624.

Ho, K.M., Burrell, M., Rao, S. and Baker, R. (2010) Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study. British Journal of Anaesthesia, 105 (5). pp. 596-602.

Gardiner, E.E., Thom, J.Y., Al-Tamimi, M., Hughes, A., Berndt, M.C., Andrews, R.K. and Baker, R.I. (2010) Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura. British Journal of Haematology, 149 (4). pp. 625-628.

Rauch, A., James, I., Pfafferott, K., Nolan, D., Klenerman, P., Cheng, W., Mollison, L., McCaughan, G., Shackel, N., Jeffrey, G.P., Baker, R., Freitas, E., Humphreys, I., Furrer, H., Günthard, H.F., Hirschel, B., Mallal, S., John, M., Lucas, M., Barnes, E. and Gaudieri, S. (2009) Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology, 50 (4). pp. 1017-1029.

Gaudieri, S., Rauch, A., Pfafferott, K., Barnes, E., Cheng, W., McCaughan, G., Shackel, N., Jeffrey, G.P., Mollison, L., Baker, R., Furrer, H., Günthard, H.F., Freitas, E., Humphreys, I., Klenerman, P., Mallal, S., James, I., Roberts, S., Nolan, D. and Lucas, M. (2009) Hepatitis C virus drug resistance and immune-driven adaptations: Relevance to new antiviral therapy. Hepatology, 49 (4). pp. 1069-1082.

Flanagan, D., MacLellan, D., Gibbs, H., Baker, R. and Fletcher, J. (2008) The insidious hazard of hospitalisation: Venous thromboembolism. Medicine Today, 9 (9). pp. 16-26.

Conference Item

Pfafferott, K., Merani, S., Rauch, A., Baccala, M., Mallal, S., Baker, R., Gaudieri, S. and Lucas, M. (2010) One step closer to a CTL-based HCV vaccine. In: The Australian Centre for HIV and Hepatitis Virology Research (ACH2) 6th National Workshop, 23 - 25 June 2010, Yarra Valley, Australia.

Gaudieri, S., Rauch, A., James, I., Pfafferott, K., Baker, R., Cheng, W., McCaughan, G., Shackel, N., Jeffrey, G., Mollinson, L., Mallal, S., Furrer, H., Günthard, H., Hirschel, B., Klenerman, P., Nolan, D., John, M. and Lucas, M. (2009) Co-localisation of hepatitis C virus drug-resistant mutations and immune-driven adaptations: Relevance to therapy outcome. In: 19th Annual Combined Biological Sciences Meeting 2009, 28 August 2009, Perth, Western Australia.

Lucas, M., Pfafferott, K., Baker, R., Cheng, W., Mollison, L., Baccala, M., Miczkova, S., Nazareth, S., Herrmann, S., Rauch, A. and Gaudieri, S. (2009) Correlates of infection outcome following multiple exposures to the Hepatitis C virus. In: 16th International Symposium on Hepatitis C Virus & Related Viruses, 3 - 7 October, Nice, France.

Lucas, M., Pfafferott, K., Baker, R., Baccala, M., Herrmann, S. and Gaudieri, S. (2009) HCV-specific T-cell responses reflect Hepatitis C infection outcome following multiple exposures to the virus. In: Australian Centre for HIV & Hepatitis Virology Research (ACH2) 5th National Workshop, 3 - 5 June, Terrigal, NSW, Australia.

Pfafferott, K., Gaudieri, S., Naidoo, K., Rauch, A., Baccala, M., Baker, R., Mallal, S. and Lucas, M. (2008) Population based genetic approach identifies novel hepatitis C targets of the immune response. In: 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September, Perth, Western Australia.

This list was generated on Sat Sep 20 15:01:43 2014 IST.